Fibrolamellar Cancer Foundation (FCF)

The principal purpose of the Fibrolamellar Cancer Foundation (FCF) is to encourage, drive and fund research that will substantially improve outcomes for patients with fibrolamellar carcinoma (FLC), a rare form of liver cancer that primarily occurs in adolescents and young adults who have no history of liver disease. Given the urgent need for clinically-proven therapies for this disease, our mission is three-fold: (1) find a cure and effective treatment options for FLC; (2) connect and support the fibrolamellar community; and (3) raise awareness of this disease.